Request Demo
Last update 19 Jun 2026
GD2-SADA:177Lu-DOTA Complex
Last update 19 Jun 2026
Overview
Basic Info
Drug Type Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals |
Synonyms GD2-SADA-177Lu-Proteus |
Target |
Action modulators |
Mechanism GD2 modulators(Disialoganglioside GD2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with GD2-SADA:177Lu-DOTA ComplexNCT05130255
Phase 1 Trial With GD2-SADA:177Lu-DOTA Drug Complex in Patients With Recurrent or Refractory Metastatic Solid Tumors Known to Express GD2, Including Small Cell Lung Cancer, High Risk Neuroblastoma, Sarcoma and Malignant Melanoma
100 Clinical Results associated with GD2-SADA:177Lu-DOTA Complex
Login to view more data
100 Translational Medicine associated with GD2-SADA:177Lu-DOTA Complex
Login to view more data
100 Patents (Medical) associated with GD2-SADA:177Lu-DOTA Complex
Login to view more data
100 Deals associated with GD2-SADA:177Lu-DOTA Complex
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| High Risk Neuroblastoma | Phase 1 | United States | 17 Nov 2022 | |
| Melanoma | Phase 1 | United States | 17 Nov 2022 | |
| Metastatic Solid Tumor | Phase 1 | United States | 17 Nov 2022 | |
| Sarcoma | Phase 1 | United States | 17 Nov 2022 | |
| Small Cell Lung Cancer | Phase 1 | United States | 17 Nov 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 23 | GD2-SADA (Cohort 1) | flvcpvmswm = hcsfxdaoet ogdbtgwdrw (fzavzkwywp, lhuilsfawp - xqufvyirbn) View more | - | 18 Jun 2026 | ||
GD2-SADA (Cohort 2) | flvcpvmswm = pmvrxslewr ogdbtgwdrw (fzavzkwywp, qorhnzxqkq - llngkrllhb) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free